Differences between children with severe acute lower respiratory infection with or without SARS-Cov-2 infection

Vivian Botelho Lorenzo1, Cristiana M Nascimento-Carvalho2

  • 1Post-graduate Program in Health Sciences, Federal University of Bahia School of Medicine, Praça Ramos de Queirós, Largo Terreiro de Jesus, s/n, Salvador, Brazil.

Insights

Children with severe acute lower respiratory infection (ALRI) and SARS-CoV-2 require more invasive mechanical ventilation (IMV) and have higher mortality rates. This highlights the critical impact of SARS-CoV-2 on pediatric respiratory illness outcomes.

Area of Science:

  • Pediatric Intensive Care
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Severe acute lower respiratory infection (ALRI) is a significant cause of pediatric morbidity.
  • The impact of SARS-CoV-2 on pediatric ALRI requires further investigation, particularly in intensive care settings.

Discussion:

  • This study compared clinical features and outcomes of children with severe ALRI, with and without SARS-CoV-2 infection, admitted to a Pediatric Intensive Care Unit (PICU).
  • Patients with SARS-CoV-2 infection showed a higher incidence of male gender and sickle cell disease.
  • Wheezing was more prevalent in children without SARS-CoV-2 infection.

Key Insights:

  • Children with severe ALRI and SARS-CoV-2 infection had significantly higher rates of invasive mechanical ventilation (IMV) (25.8% vs. 11.5%).
  • Mortality was also elevated in the SARS-CoV-2 positive group (8.1% vs. 2.0%).
  • These findings underscore the increased severity of ALRI in children infected with SARS-CoV-2.

Outlook:

  • Further research is needed to understand the long-term respiratory consequences of SARS-CoV-2 in children.
  • Developing targeted treatment strategies for pediatric ALRI associated with SARS-CoV-2 is crucial.
  • Public health initiatives should focus on preventing severe respiratory infections in pediatric populations, especially during viral outbreaks.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
592
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
474
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
258
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.4K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
432